{"document": {"publication": "Tag My News", "full_text": "japan's largest drugmaker takeda pharmaceutical is in talks to buy privately held swiss rival nycomed for more than $12 billion to extend its global reach into europe and emerging markets, according to sources with direct knowledge of the matter.", "title": "takeda seeks global reach with $12 billion nycomed bid", "line_count": 1, "filename": "18739", "publication_date": "12-05-2011 18:01:15", "lines_and_colors": [["japan's largest drugmaker takeda pharmaceutical is in talks to buy privately held swiss rival nycomed for more than $12 billion to extend its global reach into europe and emerging markets, according to sources with direct knowledge of the matter.", {}]]}}